What is over the counter derivative

23 Feb 2022|

1 min read |

by ICICI Securities Team

Introduction:

In capital markets, derivatives have no intrinsic value but derive their value through their underlying asset. The first official derivatives took place in 1848, Chicago. It was a forward contract where the derivatives derived their value from wheat. Today this underlying value could come from bonds, stocks, commodities, currencies, etc. In the absence of a supervisory exchange market, there are no limits to the lot size of the securities being traded. That allows the parties to fit their contracts with their requirements after accessing the risk factors. Companies that cannot list themselves on formal stock exchanges sell their stocks through the counter platform. That allows them to gauge market and counterparty risks and proceed with caution.

Advantages of OTC derivatives

In global finance, OTC derivatives (and OTC markets in general) have a special place for ensuring the movement of and access to capital, especially for companies that are yet to enlist and trade on formal centralized exchanges. This means:

Trading of less liquid companies: OTC derivatives help buy or sell smaller and less liquid assets, thus contributing to the overall flow of capital
The flexibility of traded items: OTC traders are more flexible in tailoring their contracts according to market risks
Non-standardized items: OTC markets have no limit on the quantity and quality of the items being traded
Hedging instruments: OTC derivatives are cost-effective ways to access stocks before investing in them further

Additional read: What are the different instruments available in India under the derivative segment?

Disadvantages of OTC derivatives

While OTC markets afford greater flexibility to traders regarding their contract specifications, their risks are relatively higher than trading through formal stock exchanges. These include:

Higher credit risk: Being unregulated by a supervisory body, derivatives traded on the OTC platform have increased credit or default risk
Illiquidity: If there are no buyers to derivative securities, it may lead to a liquidity impasse. On the other hand, a regulated exchange market ensures trading without interruptions
Lack of transparency: Unlike a regulated exchange market where there is mandatory public disclosure of the price at which the trading occurs, OTC counterparties are not obligated to do so. Hence a buyer may end up buying a stock for more than what it’s worth

An example of OTC derivatives:

A forward contract is a clear example of OTC derivatives. It is a non-regulated, non-standardized, and customized contract between a buyer and a seller. The two parties negotiate the terms of the agreement and settle it only after its expiration date.

Additional read: What is the difference between a Futures contract and a Forward Contract?

Conclusion:

Though they offer more flexibility and customization to the contracts, OTC derivatives are riskier than listed securities traded through formal stock exchanges. However, OTC markets are significant in ensuring access to and flow of capital among the smaller players.

Disclaimer

ICICI Securities Limited has its registered office at ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. The non-broking products / services like iLearn and Financial Learning are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism. iLearn is not an exchange traded product/service of ICICI Securities Ltd. All disputes with respect to the activity on the platform would not have access to Exchange investor redressal or Arbitration mechanism.

ICICI Securities Ltd. is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. ICICI Securities Ltd. is a SEBI registered with SEBI as a Research Analyst vide registration no. INH000000990. Name of the Compliance officer (broking): Mr. Atul Agrawal, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com Investments in securities markets are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. ICICI Securities Ltd. and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. AMFI Regn. No.: ARN-0845. PFRDA registration numbers: POP no -05092018. ICICI Securities Ltd. acts as a Composite Corporate agent having registration number -CA0113. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully. Please note, Mutual Fund, Corporate Fixed Deposits, Bonds, Alternate investment funds, Tax planning, Succession planning, NPS, IPO, Investment Advisory and Loans related services are not Exchange traded products and ICICI Securities Ltd. is acting as a distributor to solicit these products. Please note, Insurance related services are not Exchange traded products and ICICI Securities Ltd. is acting as a corporate agent to solicit these products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The non-broking products / services like Research, etc. are not exchange traded products / services and all disputes with respect to such activities would not have access to Exchange investor redressal or Arbitration mechanism. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.